ASPE Conversion Disclosure
Hasnain Faheem · SEC Form 4 · Filed Nov 2, 2026
Conversion
Reported value range
Not reported
Hasnain Faheem Executive Chair
ASPE
Transaction date
Nov 2, 2026
Public filing date
Nov 2, 2026
Filing lag
Filed same day
ASPE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series C Convertible Preferred Stock on Common Stock
- Quantity / price
- 7,120 shares
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001193125-26-444126
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE Current | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |